Work

Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

Year: 2011

Type: article

Study design: Observational Study

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-11-0269

Authors: Seung Tae Kim, Do Hyoung Lim, Kee-Taek Jang, Taekyu Lim, Jeeyun Lee, Yoon-La Choi, Hye-Lim Jang, Jun Ho Yi, Kyung Kee Baek, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park

Institutions: Samsung Medical Center, Samsung Biomedical Research Institute, Sungkyunkwan University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2117808097

FWCI: 5.735

Cites: 27

Cited by: 145

Related to: 10